Adverse drug reactions in older Australians, 1981-2002

Medical Journal of Australia

Volumn 182, Issue 6, 2005, Pages 267-270

  Burgess, Christel L ^a   Holman, C D'Arcy J ^a   Satti, Anthony G ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Health Information Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIPARKINSON AGENT; ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; BACTERIAL VACCINE; CARDIOVASCULAR AGENT; CENTRAL DEPRESSANT AGENT; CENTRAL STIMULANT AGENT; CORTICOSTEROID; CYTOTOXIC AGENT; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; HORMONE DERIVATIVE; HYPNOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PSYCHOTROPIC AGENT; RESPIRATORY TRACT AGENT; SEDATIVE AGENT;

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CASE STUDY; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HOSPITAL INFORMATION SYSTEM; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIVATE HOSPITAL; PUBLIC HOSPITAL; SEX DIFFERENCE; SIDE EFFECT;

EID: 15844400122     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06698.x     Document Type: Article

References (20)

1. WHO Collaborating Centre for International Drug Monitoring. The global intelligence network for benefits and risks in medical products. Uppsala: WHO Uppsala Monitoring Centre, 2003. Available at: www.who-umc.org/defs.html (accessed Aug 2003).
2. Gallagher LP. The potential for adverse drug reactions in elderly patients. Appl Nurs Res 2001; 14: 220-224.
3. Dawes VP. Poisoning in Western Australia: overview, investigation of therapeutic poisoning in the elderly [MPH dissertation]. Perth: University of Western Australia, 1994. Abstract available at: www.populationhealth.uwa.edu.au/dawesl994 (accessed Jun 2004).
4. Commonwealth Department of Health and Ageing. National Medicines Policy - Quality Use of Medicines. Canberra: The Department, 2002. Available at: www.health.gov.au/haf/nmp/quality.htm (accessed Oct 2003).
5. Commonwealth Department of Health and Ageing. National Medicines Policy - National Prescribing Service. Health Access and Financing Division. Canberra: the Department, 2003. Available at: www.health.gov.au/haf/nmp/prescribers/nps.htm (accessed Oct 2003).
6. World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death, 9th revision. Geneva: WHO, 1977.
7. National Coding Centre. Australian version of the international classification of diseases, 9th revision, clinical modification (ICD-9-CM). Sydney: National Coding Centre, 1995.
8. National Centre for Classification in Health. The international statistical classification of diseases and related health problems, 10th revision, Australian modification (ICD-10-AM). Sydney: National Centre for Classification in Health, 1999.
9. Roughead EE. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999; 19: 19-22.
10. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1016.
11. Wilson RM, Runciman WB, Gibberd RW, et al. The quality in Australian health care study. Med J Aust 1995; 163: 458-471.
12. Commonwealth Department of Health and Ageing. Cost to government of pharmaceutical benefits. Health Access and Financing Division. Canberra: The Department, 2003. Available at: www.health.gov.au/pbs/pbs/phbeninf.htm (accessed Jul 2003).
13. Gibian T. Rational drug therapy in the elderly or how not to poison your elderly patients. Aust Fam Physician 1992; 21: 1755-1760.
14. Donnan G. National Health and Medical Research Council releases draft clinical practice guidelines for stroke prevention - the role of anticoagulants, antiplatelets and carotid endarterectomy. Canberra: NHMRC, 1996. Available at: www.health.gov.au/nhmrc/media/96release/stroke.htm (accessed Oct 2003).
15. Siahpush M. Why do people favour alternative medicine? Aust N Z J Public Health 1999; 23: 266-271.
16. Brameld KJ, Holman CDJ, Threllfall TJ, et al. Increasing 'active prevalence' of cancer in Western Australia and its implications for health services. Aust N Z J Public Health 2002; 26: 164-169.
17. Dartnell JG, Anderson RP, Chohan V, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164: 659-662.
18. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205.
19. Commonwealth Department of Health and Ageing. Australian statistics on medicines 1999-2000. Canberra: The Department, 2003.
20. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers Criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.